Drug ID:   | NPD9466 |
Drug Name:   | ACEA-1031 |
Molecular Formula:   | C8H3Br2N3O4 |
Canonical SMILES:   | Brc1cc2[nH]c(=O)c(=O)[nH]c2c(c1Br)N(=O)=O |
Standard InCHI:   | InChI=1S/C8H3Br2N3O4/c9-2-1-3-5(6(4(2)10)13(16)17)12-8(15)7(14)11-3/h1H,(H,11,14)(H,12,15) |
Standard InCHIKey:   | HPDZNXVZXICVSF-UHFFFAOYSA-N |
Max Developmental Stage:   | Discontinued |
Max Developmental Stage Source:   | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
Similarity Level | Similarity Score | Natural Product ID |
---|---|---|
Remote Similarity | 0.6794 | NPC313362 |
Remote Similarity | 0.5783 | NPC13526 |
Remote Similarity | 0.5634 | NPC20322 |
TTD   | DIB000709 |
DrugBank   | |
ChEMBL   | |
IUPHAR/BPS   | |
PharmaGKB   | |
KEGG Drug   | |
PubChem CID   | |
ChEBI   | |
CAS Number   |
Molecular Weight   | 362.85 |
ALogP   | 1.1681 |
MLogP   | 1.35 |
XLogP   | 3.231 |
HDA   | 4 |
HBD   | 2 |
Rotatable Bonds   | 4 |
TPSA   | 101.34 |
RO5 Violation   | 0 |